X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Cadila Healthcare with Unichem Lab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs UNICHEM LAB - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE UNICHEM LAB CADILA HEALTHCARE/
UNICHEM LAB
 
P/E (TTM) x 21.7 24.7 87.9% View Chart
P/BV x 5.4 2.3 233.6% View Chart
Dividend Yield % 0.9 1.1 78.8%  

Financials

 CADILA HEALTHCARE   UNICHEM LAB
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-17
UNICHEM LAB
Mar-17
CADILA HEALTHCARE/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs460320 143.8%   
Low Rs305221 138.0%   
Sales per share (Unadj.) Rs92.1167.2 55.1%  
Earnings per share (Unadj.) Rs14.812.0 123.9%  
Cash flow per share (Unadj.) Rs18.516.9 109.2%  
Dividends per share (Unadj.) Rs3.203.00 106.7%  
Dividend yield (eoy) %0.81.1 75.4%  
Book value per share (Unadj.) Rs68.0117.0 58.1%  
Shares outstanding (eoy) m1,023.7490.88 1,126.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.21.6 256.7%   
Avg P/E ratio x25.822.6 114.2%  
P/CF ratio (eoy) x20.716.0 129.6%  
Price / Book Value ratio x5.62.3 243.5%  
Dividend payout %21.625.1 86.1%   
Avg Mkt Cap Rs m391,58124,578 1,593.2%   
No. of employees `00016.95.2 324.8%   
Total wages/salary Rs m15,0022,487 603.1%   
Avg. sales/employee Rs Th5,594.52,928.3 191.0%   
Avg. wages/employee Rs Th890.1479.4 185.7%   
Avg. net profit/employee Rs Th899.9209.4 429.7%   
INCOME DATA
Net Sales Rs m94,29515,195 620.6%  
Other income Rs m1,286110 1,167.0%   
Total revenues Rs m95,58115,305 624.5%   
Gross profit Rs m19,0361,788 1,064.7%  
Depreciation Rs m3,750452 830.0%   
Interest Rs m45034 1,335.3%   
Profit before tax Rs m16,1221,413 1,141.3%   
Minority Interest Rs m3380-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-30-   
Tax Rs m1,289326 395.6%   
Profit after tax Rs m15,1681,087 1,395.7%  
Gross profit margin %20.211.8 171.6%  
Effective tax rate %8.023.1 34.7%   
Net profit margin %16.17.2 224.9%  
BALANCE SHEET DATA
Current assets Rs m60,2236,426 937.2%   
Current liabilities Rs m53,0583,917 1,354.4%   
Net working cap to sales %7.616.5 46.0%  
Current ratio x1.11.6 69.2%  
Inventory Days Days7068 103.2%  
Debtors Days Days8877 114.5%  
Net fixed assets Rs m72,9847,410 985.0%   
Share capital Rs m1,024182 563.3%   
"Free" reserves Rs m68,57610,454 656.0%   
Net worth Rs m69,60010,636 654.4%   
Long term debt Rs m24,6844 561,000.0%   
Total assets Rs m152,20715,258 997.6%  
Interest coverage x36.842.9 85.8%   
Debt to equity ratio x0.40 85,731.4%  
Sales to assets ratio x0.61.0 62.2%   
Return on assets %10.37.3 139.7%  
Return on equity %21.810.2 213.3%  
Return on capital %17.913.6 131.9%  
Exports to sales %024.1 0.0%   
Imports to sales %04.9 0.0%   
Exports (fob) Rs mNA3,666 0.0%   
Imports (cif) Rs mNA752 0.0%   
Fx inflow Rs m21,2805,298 401.6%   
Fx outflow Rs m10,8740-   
Net fx Rs m10,4065,298 196.4%   
CASH FLOW
From Operations Rs m13,495683 1,974.7%  
From Investments Rs m-29,103-1,316 2,212.3%  
From Financial Activity Rs m23,158592 3,910.5%  
Net Cashflow Rs m7,556-40 -18,937.3%  

Share Holding

Indian Promoters % 74.8 50.1 149.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 15.1 55.0%  
FIIs % 5.9 3.0 196.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 31.7 34.7%  
Shareholders   44,069 20,176 218.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   STERLING BIOTECH  SANOFI INDIA  ALKEM LABORATORIES  ORCHID PHARMA LTD  NOVARTIS  

Compare CADILA HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Share Markets Extend Gains; Energy & PSU Stocks Rally(12:30 pm)

Stock markets in India continue to trade higher taking cues from their key Asian counterparts. Sectoral indices are trading in green with stocks in the oil & gas sector.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Beware the 5th year of the Modi Regime(The Honest Truth)

May 22, 2018

2017 was a great year for the market. You were rewarded for taking excessive risk. But Ajit Dayal believes 2018 will be different. You will be rewarded for doing the opposite. Read on to know more...

Beware of Inflated Stock Market Angels(Sector Info)

May 17, 2018

The stock of Vakrangee helps us understand why it's a bad idea to chase high-flying stocks.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


May 28, 2018 02:53 PM

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 5-YR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS